%0 Journal Article
%T Lowİ\dose suramin in autism spectrum disorder: a small, phase I/II, randomized clinical trial
%A A. Taylor Bright
%A Alan Lincoln
%A Brooke Curtis
%A Cynthia Adams
%A Deyna A. Arellano
%A Edmund V. Capparelli
%A Feng He
%A Gail E. Reiner
%A Jeanne Townsend
%A Ji Sun
%A Kefeng Li
%A Leanne Chukoskie
%A Lin Wang
%A Lisa E. Mash
%A Marissa Westerfield
%A Robert K. Naviaux
%A Sonia Jain
%A Suzanne Goh
%A William A. Alaynick
%J Archive of "Annals of Clinical and Translational Neurology".
%D 2017
%R 10.1002/acn3.424
%X No drug is yet approved to treat the core symptoms of autism spectrum disorder (ASD). Lowİ\dose suramin was effective in the maternal immune activation and Fragile X mouse models of ASD. The Suramin Autism Treatmentİ\1 (SATİ\1) trial was a doubleİ\blind, placeboİ\controlled, translational pilot study to examine the safety and activity of lowİ\dose suramin in children with ASD
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497533/